Intellectual Property - Biosequence Status Analysis

Get most out of your sequences

Are my clones worth further investments? That is the key question for all biological screening applications.

With Biosequence Status Analysis you proof the legal status of a clone sequence. For doing this you screen databases of already patented DNA and protein data for your sequence. This might tell you ahead of time which clone has a potential and is worth further investment.

One is for sure: if you rely on public databases, like NCBI, you are lost because they definitely do cover neither the complete nor the latest data stock. Tools for reliable and extensive investigations are specialist databases covering biosequences registered by patent authorities, like REGISTRY, DGENE and PCTGEN (via STN), or - on a basic level - the SRS-System.

For successful homology and analogy searches the investigator should be well trained in sequence comparison studies and the judgement of the corresponding results. The major challenge with similarity searches in fact is not using the databases but interpreting the results. Experience is the key to success.

scitari has up-to-date competence as well as proofed experience with the successful analysis of biosequences.

back to top

scitari assists you to get most out of patent information.

We already support top patent attorneys and biotech enterprises with patent and technology information research. We have access to an extensive set of international patent, literature and technology databases.

We carry out one-time searches as well as regular patent monitoring. We offer particular expertise in the field of sequence analysis (DNA, protein) with databases for already patented sequences.

We are the specialists for ...

• State-of-the-art Investigations
• Patent Literature Analysis
• Sequence Status Analysis
• Patent Status Monitoring
• and more ...

Contact us! Use our expertise and competence.